期刊文献+

帕金森病患者运动症状进展及运动并发症危险因素纵向分析 被引量:3

A longitudinal study of the progression of motor symptoms and risk factors of motor complications in Parkinson' s disease
原文传递
导出
摘要 目的观察帕金森病(Parkinson’s disease,PD)患者运动症状的进展及运动并发症的发生情况,探讨运动症状的进展速度及运动并发症发生的危险因素。方法随访2007年在新华医院神经内科确诊的PD患者130例,随访时间为3年。采用统一PD评分量表(UPDRS)和H—Y分级评估及随访130例患者运动症状进展及运动并发症发生情况,统计并分析运动症状的进展速度及运动并发症发生的危险因素。结果(1)PD患者H-Y分级平均年增长2.5%,UPDRSH1分数平均年增长3.1%;随访末患者吞咽困难发生率较基线增加23.0%;跌倒发生率增加16.7%;(2)异动症的独立危险因素为:随访末左旋多巴的剂量(OR=1.004,95%CI1.001—1.006,P=0.008);症状波动的独立危险因素为:病程(OR=1.637,95%C11.083~2.473,P=0.019),左旋多巴用药时间(OR=0.698,95%C10.494—0.987,P=0.042),入组时(OR=1.005,95%CI1.001-1.010,P=0.016)及随访末左旋多巴剂量(OR=1.014,95%CI1.001~1.027,P=0.032)。结论随病程进展,PD患者的运动症状逐渐加重,吞咽困难和跌倒的发生率上升,运动并发症的发生率增加。左旋多巴的暴露总量是PD患者出现运动并发症的预测因素。 Objective To observe progression of motor symptoms and occurrence of motor complications in parkinsonian patients and investigate the rate of progression of motor symptoms and risk factors of motor complications. Methods One hundred and thirty patients diagnosed with PD in 2007 in Department of Neurology, Xinhua Hospital were followed up for 3 years. The Unified Parkinson' s Disease Rating Scale (UPDRS) and H-Y staging were used to assess and follow up motor symptoms and occurrence of motor complications, and analyze the rate of progression of motor symptoms and risk factors of motor complications with statistics. Results ( 1 ) Mean annual growth in H-Y staging was 2.5%, and UPDRS motor scores was 3.1%; the incidence of dysphagia at endpoint in patients was increased by 23.0% compared with baseline; incidence of falls was increased by 16. 7%;(2)Daily levodopa dose at endpoint ( OR = 1. 004,95% CI 1. 001--1. 006, P = 0. 008 ) was independent risk factors with dyskinesia; While duration ( OR = 1. 637,95% CI 1. 083--2. 473, P = 0. 019 ), levodopa treatment duration ( OR = 0. 698, 95% CI O. 494---0. 987, P = 0. 042), daily levodopa dose at baseline ( OR = 1. 005,95% C1 1. 001- 1. 010 ,P =0. 016) and at endpoint ( OR = 1. 014,95% CI 1. 001-1. 027 ,P =0. 032) were risk factors with motor fluctuations. Conclusions As the disease progresses, motor function in parkinsonian patients gradually worsens, the incidence of swallowing difficuhy and of falls is increased, and the incidence of motor complications is increased. The total exposure to levodopa in parkinsonian patients is predictor for motor complications.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2012年第6期382-386,共5页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(81071025) 上海市教育委员会科研创新重点项目资助(IOZZ72)
关键词 帕金森病 运动障碍 发病率 纵向研究 Parkinson disease Movement disorders Incidence Longitudinal studies
  • 相关文献

参考文献20

  • 1孙圣刚,王岚.帕金森病神经保护治疗现状[J].中华神经科杂志,2007,40(2):73-75. 被引量:4
  • 2Goetz CG. What' s new? Ctinical progression and staging of Parkinson' s disease. J Neural Transm Suppl, 2006, 70: 305- 308.
  • 3Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology, 2001, 57(10 Suppl 3): S11-26.
  • 4周明珠,刘振国,干静,陆丽霞,吴佳英,陈伟.帕金森病患者运动并发症的调查分析[J].中华神经科杂志,2008,41(11):744-747. 被引量:17
  • 5周明珠,刘振国,干静,陈伟,陆丽霞,吴佳英.帕金森病患者神经精神症状的调查分析[J].中华医学杂志,2008,88(21):1442-1445. 被引量:4
  • 6干静,周明珠,刘振国,陈伟,陆丽霞,吴佳英.帕金森病患者自主神经功能障碍评估[J].中国临床神经科学,2008,16(3):251-256. 被引量:14
  • 7张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 8Minguez-Castellanos A, Eseamilla-Sevilla F, Katati MJ, et al. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson' s disease : target related effect or selection bias? J Neurol Neurosurg Psychiatry, 2005, 76: 34-39.
  • 9Gan J, Xie-Brustolin J, Mertens P, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson' s disease: three years follow-up. J Neurol, 2007, 254:99-106.
  • 10Schrage A, Dodel R, Spottke A, et al. Rate of clinical progression in parkinson' s disease. A prospective study. Mov Disord, 2007, 22 : 938-945.

二级参考文献68

  • 1Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson' s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep, 2005, 5: 275-283.
  • 2Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol, 2006,5:235-245.
  • 3Lieberman A. Are dementia and depression in Parkiuson's disease related.? J Neurol Sci ,2006,248:138-142.
  • 4Richard IH. Anxiety disorders in Parkinson's disease. Adv Neurol, 2005,96:42-55.
  • 5Diederich N J, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord, 2005,20 : 130-140.
  • 6Isella V, Melzi P, Grimaldi M, et al. Clinical, neuropsyehologieal, and morphometric correlates of apathy in Parkinson's disease. Mov Disord. 2002.17:366-371.
  • 7The Parkinson's Disease Questionnaire (PDQ-39) : development and validation of a Parkinson's disease summary index score. Age Ageing, 1997,26 : 353.
  • 8Starkstein SE, Jorge R, Mizrahi RA. The prevalence, clinical correlates and treatment of apathy in Alzheimer's disease. Eur J Psychiat ,2006,20:96-106.
  • 9Lieberman A. Depression in Parkinson's disease- a review. Acta Neurol Scand ,2006,113 : 1-8.
  • 10Kopell BH, Greenberg B, Rezai AR,et al. Deep brain stimulation for psychiatric disorders. J Clin Neurophysiol, 2004,21:51-67.

共引文献645

同被引文献27

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2Mak MK, Pang MY. Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features [ J ]. Neurol, 2010, 257: 1543-1551.
  • 3Allan LM, Ballard CG, Rowan EN, et al. Incidence and prediction of falls in dementia: a prospective study in older people [J]. Plos One, 2009, 4: e5521.
  • 4Vossius C, Nilsen OB, Larsen JP. Parkinson' s disease and hospital admissions : frequencies, diagnoses and costs [ J ]. Acta Neurol Scand, 2010, 121: 38-43.
  • 5Martignoni E, Godi 1, Citterio A, et al. Comorbid disorders and hospitalization in Parkinson' disease : a prospective study [ J ]. Neurol Sci, 2004, 25: 66-71.
  • 6Hiorth YH, Lode K, Larsen JP. Frequencies of falls and associated features at different stages of Parkinson' s disease [ J ]. Eur J Neurol, 2013, 20: 160-166.
  • 7Rudzihska M, Bukowczan S, Stozek J, et al. The incidence and risk factors of falls in Parkinson disease : prospective study [ J ]. Neurol Neurochir Pol, 2013, 47: 431-437.
  • 8Bloem BR, Grimbergen YA, Cramer M, et al. Prospective assessment of falls in Parkinson' s disease [ J ]. Neurol, 2001, 248 : 950-958.
  • 9Roiz Rde M, Cacho EW, Pazinatto MM, et al. Gait analysis comparing Parkinson' s disease with healthy elderly subjects [ J ]. Arq Neuropsiquiatr, 2010, 68: 81-86.
  • 10Carpenter MG, Alum JH, Honegger F, et al. Postural abnormalities to multidirectional stance perturbations in Parkinson' s disease [ J ]. J Neurol Neurosurg Psychiatry, 2004, 75 : 1245-1254.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部